View Older Stories View More Recent Stories
-
3 healthcare services stocks for 2026: RBC
-
Motive Files Registration Statement for Proposed Initial Public Offering
-
MDA SPACE completes C$250 million notes offering to refinance debt
-
MDA SPACE ANNOUNCES CLOSING OF C$250 MILLION OFFERING OF SENIOR UNSECURED NOTES DUE 2030
-
CWAN Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Clearwater Analytics to Permira and Other Investors
-
CWAN Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Clearwater Analytics to Permira and Other Investors
-
RBC Capital on Cintas (CTAS): 'esilience and Growth Amid Macro Uncertainty'
-
Rollins (ROL) PT Raised at RBC Capital; 'Steady Gains in a Shifting Macro Landscape'
-
APi Group Corporation (APG) PT Raised to $45 at RBC Capital
-
BRP completes secondary offering as Bain Capital sells 1.85 million shares
-
BRP and its Principal Shareholder Announce Closing of Previously Announced Secondary Offering
-
Primo Brands to Participate in a Virtual Fireside Chat with RBC Capital Markets
-
2Life Communities Breaks Ground on Solimine House in Lynn
-
Form MA-I/A RBC Capital Markets,
-
Form MA-I/A RBC Capital Markets,
-
Form MA-I/A RBC Capital Markets,
-
Form MA-I/A RBC Capital Markets,
-
RBC upgrades Health Care and Communication Services in S&P 500 sector view
-
RBC Capital: 'We Believe the Deal Undervalues Clearwater Analytics Holdings (CWAN)'
-
RBC Capital: "Our Preference in CY26 is TD Synnex (SNX) Over INGM'
-
Ingram Micro (INGM) PT Lowered at RBC Capital on 'Slower Topline Growth'
-
Wendy's (WEN) PT Lowered to $8.50 at RBC Capital
-
HEICO (HEI) PT Raised to $375 at RBC Capital
-
Cytokinetics (CYTK) PT Raised to $95 at RBC Capital
-
ConAgra (CAG) PT Lowered to $20 at RBC Capital
-
RBC Capital Reiterates Outperform Rating on The Pennant Group (PNTG)
-
PACS Group (PACS) PT Raised to $47 at RBC Capital
-
Conagra retains annual forecasts, takes $968 million charge in Q2 amid muted demand
-
RBC Capital Reiterates Sector Perform Rating on Cintas (CTAS)
-
RBC Capital Reiterates Sector Perform Rating on FactSet Research Systems (FDS)
-
KB Home (KBH) PT Lowered to $54 at RBC Capital
-
CarMax (KMX) PT Raised to $37 at RBC Capital
-
Huntington Bancshares (HBAN) PT Raised to $20 at RBC Capital
-
RBC Capital Reiterates Sector Perform Rating on BlackBerry Limited (BB)
-
Medline closes $7.2 billion IPO with full underwriter option exercise
-
Medline Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
RBC: 'We have just confirmed that a recent clinicaltrials.gov listing for a new drug called BIIB145'
-
Pyxis Oncology Inc. (PYXS) PT Lowered to $5 at RBC Capital
-
Accenture plc (ACN) PT Raised to $295 at RBC Capital
-
The University of Akron reaches financial close on transformative $161 million student housing public-private partnership
-
EQB CEO to present at RBC Capital Markets conference Jan. 6
-
EQB Chief Executive Officer Chadwick Westlake to speak at RBC Capital Markets 2026 Canadian Bank CEO Conference
-
Union Pacific (UNP) PT Lowered to $280 at RBC Capital
-
Norfolk Southern (NSC) PT Raised to $325 at RBC Capital
-
CSX (CSX) PT Lowered to $40 at RBC Capital
-
Canadian National Railway (CNR:CN) (CNR) PT Lowered to Cdn$153 at RBC Capital
-
Premium Brands Holdings Corp. (PBH:CN) (PRBZF) PT Raised to Cdn$132 at RBC Capital
-
Insmed (INSM) PT Lowered to $195 at RBC Capital
-
RBC Capital Reiterates Outperform Rating on Coursera Inc (COUR)
-
RBC Capital Starts Blackline Safety Corp (BLN:CN) (BLKLF) at Outperform
